Why has the pharma industry and its talents lost interest in developing new antibiotics?
List view / Grid view
Filter the results
The UK MHRA has issued an alert for the recall of unexpired Zantac products made by GSK due to the possible contamination of ranitidine in the medicines.
Nucala is the first biologic approved in the US for six- to 11-year-old children with severe eosinophilic asthma by the FDA.
Kenya has become the third African country to introduce the world’s first malaria vaccine into the country, in a phased pilot programme.
The worldwide trade of the cephalosporin class of antibiotics will increase to $14.1 billion by the end of 2025.
Rising temperatures will likely accelerate the spread of vector-borne diseases, resulting in an increased demand for vaccines. European Pharmaceutical Review investigates a Morgan Stanley report on the pharmaceutical beneficiaries of climate change.
A Phase III clinical development programme testing otilimab in patients with RA has begun.
According to Reuters, GSK has started the sale of some consumer health brands as it seeks to raise £1 billion.
The work of a pharmaceutical scientist requires precision, attention to detail and is of vital importance to the safety of products and ultimately patients. This section features insights from experienced scientists who’ve worked extensively in microbiological analysis, developing tests, methods and standards that help establish a foundation for the production…
A $100 million investment has been made to support long-term vaccine manufacturing capabilities in the US.
Some of the key findings show that job seekers are drawn to companies with long histories and large organisations with over 50,000 employees...
Consumer demands, a focus on sustainability and recycling, and political uncertainty in the UK are just a few challenges the packaging market had to overcome last year. Nikki Withers speaks to Ron Yakubison, Director of Pharmaceutical Packaging Operations at Merck Manufacturing and Sriman Banerjee, Head of Packaging at GSK, who…
The EU has approved a new subcutaneous formulation of Benlysta, as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus...
Clinical trial results show that two candidate Ebola vaccines can elicit immune responses after initial vaccination that last for at least one year...
The regulatory environment has a great impact on business, especially in healthcare. Non-compliance exposes companies to the risk of launch delay, delisting products from the market and out-of-stocks. Moreover, it can cause reputational damage affecting staff, consumer and shareholder confidence, reduce market opportunities, and affect the bottom line.